시장보고서
상품코드
1483137

의료 미용 시장 평가 : 제품 유형별, 용도별, 최종사용자별, 지역별, 기회, 예측(2017-2031년)

Medical Aesthetics Market Assessment, By Product Type, By Application Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

발행일: | 리서치사: Market Xcel - Markets and Data | 페이지 정보: 영문 221 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

세계 의료 미용 시장 규모는 2024-2031년 예측 기간 동안 11.44%의 CAGR로 2023년 208억 4,000만 달러에서 2031년 495억 8,000만 달러로 성장할 것으로 예상됩니다. 의료 미용은 미용 시술로도 알려져 있으며, 미용사가 미용 기기를 사용하여 최소침습적으로 시술을 통해 환자의 경험을 향상시키는 미용 기기를 사용하여 시술을 수행합니다. 이러한 장비는 신체 윤곽, 문신 제거, 제모, 피부 노화, 매몰법 등 다양한 고민에 대한 다양한 시술을 수행하는 데 있어 매우 다재다능합니다. 이 장비들은 개인의 취향에 따라 치료 옵션을 개인화할 수 있어 최대한의 만족을 보장합니다.

의료 미용 시장은 향후 몇 년 동안 크게 성장할 것으로 예상됩니다. 이 시장은 노인 인구의 증가, 기술 발전, 수술로 얻을 수 있는 수술 결과에 대한 인식 증가, 소득 및 생활 수준 향상 등의 요인으로 인해 더욱 확대될 가능성이 있습니다. 업계 내 기업과 의료진은 환자에게 최고의 도구와 미용 솔루션을 제공하기 위해 협력하고 있습니다. 공공 기관과 영리 단체 모두 양질의 솔루션을 제공하기 위해 자금을 모으고 많은 투자를 하고 있습니다. Sciton Inc.는 2023년 mJOULE 시스템의 확장을 발표하고 ClearV와 ClearSilk라는 두 가지 혈관 치료법을 추가하여 2023년 mJOULE 시스템의 확장을 발표했습니다. 이번 확장을 통해 회사는 에너지 기반 미용 기기 분야의 제품 포트폴리오를 강화하고 의료 전문가에게 고급 솔루션을 제공하는 신뢰할 수 있는 리더로 자리매김했습니다.

이 보고서는 세계 의료 미용 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업 개요 등을 제공합니다.

목차

제1장 조사 방법

제2장 프로젝트 범위와 정의

제3장 주요 요약

제4장 세계의 의료 미용 시장 전망, 2017-2031년

  • 시장 규모와 예측
  • 제품 유형별
  • 용도 유형별
  • 최종사용자별
  • 지역별
  • 기업별 시장 점유율(%), 2023년

제5장 세계의 의료 미용 시장 전망, 지역별, 2017-2031년

  • 북미
  • 유럽
  • 아시아태평양
  • 남미
  • 중동 및 아프리카

제6장 시장 매핑, 2023년

제7장 거시적 환경과 산업 구조

  • 수요 공급 분석
  • 수출입 분석
  • 밸류체인 분석
  • PESTEL 분석
  • Porter's Five Forces 분석

제8장 시장 역학

제9장 규제 프레임워크와 혁신

제10장 주요 진출 기업 상황

제11장 가격 분석

제12장 사례 연구

제13장 주요 진출 기업 전망

  • Allergan, Inc.
  • Alma Lasers Ltd.
  • Cynosure Technologies(P) Ltd.
  • Bausch Health Companies Inc.
  • Johnson & Johnson Services, Inc.
  • Boston Scientific Corporation
  • Galderma S.A.
  • Cutera, Inc.
  • Candela Corp.
  • Venus Concept Inc.

제14장 전략적 제안

제15장 문의와 면책사항

ksm 24.05.31

Global medical aesthetics market is projected to witness a CAGR of 11.44% during the forecast period 2024-2031, growing from USD 20.84 billion in 2023 to USD 49.58 billion in 2031. Medical aesthetics, also known as cosmetic procedures, are done by aestheticians using cosmetic devices that are minimally invasive and enhance the patient's experience through the procedures. These devices can be very versatile in performing different procedures that address a wide variety of concerns, such as body contouring, tattoo removal, hair removal, skin aging, implantations, and much more. These devices can personalize treatment options according to individual preferences, ensuring maximum satisfaction.

The market for medical aesthetics is anticipated to expand significantly in the upcoming years. This market has the potential to expand further due to factors such as the increasing geriatric population, technological advancements, increased awareness about the possible surgical outcomes that can be achieved through surgery, and increasing income and living standards. Companies in the industry and healthcare practitioners are collaborating to provide the best tools and cosmetic solutions for patients. Both public and commercial organisations are raising money and investing a significant amount to provide quality solutions. These massive corporations use strategic maneuvers like collaborations, investments and mergers and acquisitions to increase their presence in the market. Sciton Inc. announced the expansion of its mJOULE system in 2023, which includes two vascular treatments called as ClearV and ClearSilk. This expansion has helped the company strengthen its product portfolio in energy-based aesthetic devices and mark its position as a trusted leader in delivering advanced solutions to healthcare professionals.

Technological Advancements in the Medical Aesthetics Market

Technological developments are significantly influencing the medical aesthetics sector in developed countries. New instruments and techniques are being launched that prioritize patient pleasure, safety, and effectiveness. In dermatology, minimally invasive procedures like chemical peels, laser therapy, and microdermabrasion have become standard practices. The scope of treatment and possibilities is driving the demand for aesthetic services these procedures provide patients to address a variety of skin issues with little discomfort and downtime. With the use of advanced imaging technology, such as 3D models and high-resolution cameras, dermatologists can precisely diagnose patients' skin diseases and adjust treatment regimens accordingly. Before having operations, patients can envision possible outcomes, which promotes informed decision-making and increases overall satisfaction. The delivery of these services has been revolutionized by telemedicine platforms, enabling patients to visit dermatologists remotely and receive professional advice from the comfort of their homes.

This telemedicine has proven helpful for those who may not have easy access to specialised treatment and live in rural or underdeveloped locations. Patients may track the effectiveness of their treatments, keep an eye on the condition of their skin, and get customized skincare advice with the use of wearable technology and smartphone apps. Increased patient participation and adherence to treatment plans are encouraged by this, which eventually improves results. In 2022, GC Aesthetics, Inc. (GCA), a privately held medical technology business offering healthcare aesthetic solutions, announced the release of FixNip NRI, an innovative implant for the reconstruction of the nipple areola complex (NAC). The company has devised a solution to reconstruct the nipple areola complex for thousands of women worldwide.

Marketing and Advertising Strategies Contribute to Rising Awareness

Reputed brands provide confidence and trust to their consumers about their surgical procedures and devices through advertising. Advertising provides a forum for informing prospective patients about different cosmetic procedures, the benefits of different devices and procedures, and the expected results, guaranteeing that they have access to relevant and reliable information. Before-and-after photos, films, and visual demonstrations are frequently used in creative advertising to highlight the effectiveness of medical aesthetic equipment and help prospective patients visualize possible outcomes.

Marketers use data and consumer insights to target specific demographics and audiences to ensure that their marketing efforts reach those most likely to be interested in aesthetic procedures. Patient evaluations and testimonials, which provide real-life experiences and success stories, are widely used in advertising campaigns to build trust and credibility. Partnerships and collaborations with celebrities and social media influencers who use certain technologies or have undergone cosmetic procedures can greatly impact their fan base and quickly raise awareness and interest. To facilitate better decision-making, some clinics and device makers use interactive tools like augmented reality (AR) applications that let prospective patients see possible treatment results. For example, a special Mother's Day discount was introduced in March 2024 by an aesthetic medicine clinic named Shine Medical Cosmetic Clinic, located in Kenilworth, United Kingdom. Along with many procedures discounted by up to USD 54.28 (£50), Shine Medical Cosmetic Clinic also provides a complimentary LED treatment with each radiant glow peel. With a variety of reasonably priced treatments, Shine Medical Cosmetic Clinic, headed by Dr. Shyna Raj, hopes to assist clients in achieving their cosmetic aspirations.

Botulinum Toxin Segment Leads the Global Medical Aesthetics Market

The bacteria clostridium botulinum produces the neurotoxic protein known as botulinum toxin. Injections of botulinum toxin typically obstructs nerve signals to the targeted muscle. The muscle reduces or lessens undesirable face wrinkles because it cannot contract without a signal. Therefore, both cosmetic and non-cosmetic treatments require very diluted quantities of botulinum toxin, including the treatment of dystonia, persistent migraines, frown lines between the eyebrows, and other such conditions. The market category is expanding due to factors such as the growing popularity of botulinum toxin operations among young adults, the increasing demand for less invasive cosmetic procedures, an increase in the number of people who are mindful of their appearance, and the introduction of new products. According to the American Society of Plastic Surgeons poll, one of the most popular minimally invasive cosmetic procedures among patients is botulinum toxin Type A. Also, it was noted that patients between the ages of 31 and 45 most frequently seek out cosmetic botulinum toxin type A operations. The key competitors in the market are also making significant investments in technical advancements and increasing their import and export of products containing botulinum toxin. In September 2022, Revance Therapeutics Inc.'s USFDA authorised DAXXIFY (DaxibotulinumtoxinA-lanm) received an approval for injection to treat adults with moderate to temporarily severe frown lines (glabellar lines).

North America Dominates the Global Medical Aesthetics Market

The market for medical aesthetic devices in North America is anticipated to develop significantly because of the region's advancements in technology, growing awareness of aesthetic and minimally invasive procedures, and the rising volume of various aesthetic procedures performed in the United States and Canada. The region's high rate of aesthetic operations generates demand for aesthetic devices, which in turn propels the market's expansion. High concentration of major players in North America are promoting product launches, which is also an important factor contributing to the regional market's expansion. Mentor Worldwide LLC, a division of the Johnson & Johnson Medical Devices Companies, declared in January 2022 that the MENTOR MemoryGel BOOST breast implant for breast augmentation and reconstruction has received FDA approval. This product has supported the company to expand its portfolio in the United States market. Allergan, a division of AbbVie Inc., announced in February 2022 that JUVEDERM VOLBELLA XC received FDA approval for the treatment of infraorbital hollows in people over the age of 21.

Future Market Scenario (2024-2031F)

One of the main factors contributing to the anticipated growth of the medical aesthetics market is the increasing awareness and desire to achieve the best possible physical features in the general population. Given that technology is serving the best quality results expected by people, satisfaction level with these kinds of treatments is very high. Players in this market are expanding at an unparalleled rate, introducing advanced and efficient aesthetic surgery technologies. For instance, Cynosure released the PicoSure Pro device in June 2022, marking the most recent iteration of the PicoSure platform. PicoSure Pro is one of the first 755 nm picosecond lasers to receive FDA clearance. Similarly, Gladerma launched its FACE by Gladerma in 2023, which is an augmented reality tool. It enables the professionals and patients to preview the possible results of any injectable procedure to achieve the best results. The government is enacting new laws and generating money to enhance the quality of healthcare provided globally.

Key Players Landscape and Outlook

Several companies such as Allergan, Inc., Alma Lasers Ltd., Cynosure Technologies (P) Ltd., Bausch Health Companies Inc., Johnson & Johnson Services, Inc., Boston Scientific Corporation, Galderma S.A., Cutera, Inc., Candela Corp., Venus Concept Inc., etc., are expanding their businesses by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed cosmetology techniques and devices, to help researchers and to bring up their presence in the market.

In August 2022, the Allergan Aesthetics business unit of Allergan Healthcare India Private Limited, a Bangalore-based company, announced the launch of JUVEDERM VOLUX in India. Prior to releasing this medication on the Indian market, Allergan Aesthetics secured the required approvals from the Central Drugs Standards Control Organisation (CDSCO), according to a news statement from the firm. JUVEDERM VOLUX is an injectable implant based on hyaluronic acid that restores and enhances facial volume. It contains 3 mg of lidocaine hydrochloride and 25 mg of hyaluronic acid. With specific claims to strengthen and improve the jawline and chin, giving the appearance of a more defined and improved chin, VOLUX is a hyaluronic acid dermal filler designed for use in these areas.

Menarini India, a branch of the Italian Menarini Group, announced its entry into the aesthetics market in September 2023. The company launched 'Definisse Core Filler' in the Indian market, demonstrating a strong dedication to continuous innovation and meeting the specific needs of the country's customer base. During 'Definisse Core Filler' launch 75 aesthetic dermatologists, cosmetologists, and cosmetic surgeons from all over India received practical training to provide them the know-how to use this filler.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Medical Aesthetics Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
  • 4.2.By Product Type
    • 4.2.1.Energy-based Aesthetic Device
      • 4.2.1.1.Laser-based Aesthetic Device
      • 4.2.1.2.Radiofrequency (RF)-based Aesthetic Device
      • 4.2.1.3.Light-based Aesthetic Device
      • 4.2.1.4.Ultrasound Aesthetic Device
    • 4.2.2.Non-energy-based Aesthetic Device
      • 4.2.2.1.Botulinum Toxin
      • 4.2.2.2.Dermal Fillers and Aesthetic Threads
      • 4.2.2.3.Microdermabrasion
      • 4.2.2.4.Implants
        • 4.2.2.4.1.Facial Implants
        • 4.2.2.4.2.Breast Implants
        • 4.2.2.4.3.Other Implants
      • 4.2.2.5.Other Aesthetic Devices
  • 4.3.By Application Type
    • 4.3.1.Skin Resurfacing and Tightening
    • 4.3.2.Body Contouring and Cellulite Reduction
    • 4.3.3.Hair Removal
    • 4.3.4.Breast Augmentation
    • 4.3.5.Other Applications
  • 4.4.By End-user
    • 4.4.1.Hospitals
    • 4.4.2.Beauty Aesthetics Clinics
  • 4.5.By Region
    • 4.5.1.North America
    • 4.5.2.Europe
    • 4.5.3.Asia-Pacific
    • 4.5.4.South End-user America
    • 4.5.5.Middle East and Africa
  • 4.6.By Company Market Share (%), 2023

5.Global Medical Aesthetics Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
    • 5.1.2.By Product Type
      • 5.1.2.1.Energy-based Aesthetic Device
        • 5.1.2.1.1.Laser-based Aesthetic Device
        • 5.1.2.1.2.Radiofrequency (RF)-based Aesthetic Device
        • 5.1.2.1.3.Light-based Aesthetic Device
        • 5.1.2.1.4.Ultrasound Aesthetic Device
      • 5.1.2.2.Non-energy-based Aesthetic Device
        • 5.1.2.2.1.Botulinum Toxin
        • 5.1.2.2.2.Dermal Fillers and Aesthetic Threads
        • 5.1.2.2.3.Microdermabrasion
        • 5.1.2.2.4.Implants
          • 5.1.2.2.4.1.Facial Implants
          • 5.1.2.2.4.2.Breast Implants
          • 5.1.2.2.4.3.Other Implants
        • 5.1.2.2.5.Other Aesthetic Devices
    • 5.1.3.By Application Type
      • 5.1.3.1.Skin Resurfacing and Tightening
      • 5.1.3.2.Body Contouring and Cellulite Reduction
      • 5.1.3.3.Hair Removal
      • 5.1.3.4.Breast Augmentation
      • 5.1.3.5.Other Applications
    • 5.1.4.By End-user
      • 5.1.4.1.Hospitals
      • 5.1.4.2.Beauty Aesthetics Clinics
    • 5.1.5.United States*
      • 5.1.5.1.Market Size & Forecast
        • 5.1.5.1.1.By Value
      • 5.1.5.2.By Product Type
        • 5.1.5.2.1.Energy-based Aesthetic Device
          • 5.1.5.2.1.1.Laser-based Aesthetic Device
          • 5.1.5.2.1.2.Radiofrequency (RF)-based Aesthetic Device
          • 5.1.5.2.1.3.Light-based Aesthetic Device
          • 5.1.5.2.1.4.Ultrasound Aesthetic Device
        • 5.1.5.2.2.Non-energy-based Aesthetic Device
          • 5.1.5.2.2.1.Botulinum Toxin
          • 5.1.5.2.2.2.Dermal Fillers and Aesthetic Threads
          • 5.1.5.2.2.3.Microdermabrasion
          • 5.1.5.2.2.4.Implants
          • 5.1.5.2.2.4.1.Facial Implants
          • 5.1.5.2.2.4.2.Breast Implants
          • 5.1.5.2.2.4.3.Other Implants
          • 5.1.5.2.2.5.Other Aesthetic Devices
      • 5.1.5.3.By Application Type
        • 5.1.5.3.1.Skin Resurfacing and Tightening
        • 5.1.5.3.2.Body Contouring and Cellulite Reduction
        • 5.1.5.3.3.Hair Removal
        • 5.1.5.3.4.Breast Augmentation
        • 5.1.5.3.5.Other Applications
      • 5.1.5.4.By End-user
        • 5.1.5.4.1.Hospitals
        • 5.1.5.4.2.Beauty Aesthetics Clinics
    • 5.1.6.Canada
    • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East and Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product Type
  • 6.2.By Application Type
  • 6.3.By End-user
  • 6.4.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat From New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Regulatory Approval
  • 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Allergan, Inc.
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products and Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus and Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Alma Lasers Ltd.
  • 13.3.Cynosure Technologies (P) Ltd.
  • 13.4.Bausch Health Companies Inc.
  • 13.5.Johnson & Johnson Services, Inc.
  • 13.6.Boston Scientific Corporation
  • 13.7.Galderma S.A.
  • 13.8.Cutera, Inc.
  • 13.9.Candela Corp.
  • 13.10.Venus Concept Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제